FDA approves IV artesunate for severe malaria
Intravenous (IV) artesunate received approval from the U.S. Food and Drug Administration to treat ad...
Guideline issued for nonsevere, severe COVID-19 therapy
(HealthDay)—In an evidence-based guideline devel...
Clinical trial for drug to treat severe COVID-19 patients
Yale researchers will begin a clinical trial at Ya...
New drug can ease the side effects of medication against severe depression
About one in five Danes are affected by depression...